Medicare Enrolled

Dr. Alex Lam, MD

Rheumatology · Pembroke Pines, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
160 S FLAMINGO RD, Pembroke Pines, FL 33027
9546200011
In practice since 2006 (19 years)
NPI: 1275624264 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lam

Dr. Alex Lam is a rheumatology in Pembroke Pines, FL, with 19 years in practice. Based on federal Medicare data, Dr. Lam performed 134,361 Medicare services across 780 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lam received a total of $38,795 from 63 pharmaceutical and/or device companies across 1262 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lam is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 17% volume in FL$ $38,795 industry payments

Medicare Practice Summary

Medicare Utilization ↗
134,361
Medicare services
Top 17% in FL for rheumatology
780
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,072 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)67,200$4$11
Tocilizumab injection (Actemra)35,040$5$9
Romosozumab injection (Evenity) for osteoporosis17,221$8$13
Abatacept infusion (Orencia)7,601$34$85
Denosumab injection (Prolia/Xgeva)4,802$18$30
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle591$58$120
Office visit, established patient (30-39 min)290$89$193
Blood draw (venipuncture)288$8$15
Injection of additional new drug or substance into vein288$12$25
Administration of chemotherapy into vein, 1 hour or less288$105$215
Injection, methylprednisolone sodium succinate, up to 125 mg288$4$20
Administration of chemotherapy into vein, each additional hour177$23$46
Office visit, established patient (20-29 min)84$60$136
New patient office visit (45-59 min)79$126$254
Joint injection, major joint65$50$125
Injection, methylprednisolone acetate, 80 mg30$8$20
Injection, methylprednisolone acetate, 40 mg17$5$11
New patient office visit (30-44 min)12$84$169
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.7% high complexity
93.8% medium
0.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$38,795
Total received (2018-2024)
Avg $5,542/year across 7 years
Top 14% in FL for rheumatology
63
Companies
1,262
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,633 (58.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,397 (21.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,765 (20.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,675
2023
$2,981
2022
$3,497
2021
$3,697
2020
$10,384
2019
$11,380
2018
$4,180

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$18,299
Janssen Biotech, Inc.
$2,367
UCB, Inc.
$2,352
Novartis Pharmaceuticals Corporation
$1,214
Horizon Therapeutics plc
$1,161
PFIZER INC.
$1,014
Mallinckrodt Hospital Products Inc.
$919
GlaxoSmithKline, LLC.
$829
AstraZeneca Pharmaceuticals LP
$797
ABBVIE INC.
$777
E.R. Squibb & Sons, L.L.C.
$752
Radius Health, Inc.
$747
Lilly USA, LLC
$728
Genentech USA, Inc.
$712
Aurinia Pharma U.S., Inc.
$689
AbbVie, Inc.
$496
AbbVie Inc.
$406
Mallinckrodt LLC
$380
Celgene Corporation
$365
Horizon Pharma plc
$276
Alexion Pharmaceuticals, Inc.
$271
Mallinckrodt Enterprises LLC
$261
Janssen Scientific Affairs, LLC
$242
ANI Pharmaceuticals, Inc.
$230
DePuy Synthes Sales Inc.
$211
Actelion Pharmaceuticals US, Inc.
$185
Octapharma USA, Inc.
$185
GENZYME CORPORATION
$169
Flexion Therapeutics, Inc.
$161
Pacira Therapeutics, Inc.
$146
Hikma Pharmaceuticals USA
$122
SOBI, INC
$89
Organon LLC
$79
TerSera Therapeutics LLC
$69
MEDEXUS PHARMA, INC.
$68
GRT US Holding, Inc.
$66
Sobi, Inc
$65
Takeda Pharmaceuticals U.S.A., Inc.
$60
MEDAC PHARMA, INC.
$58
Teva Pharmaceuticals USA, Inc.
$54
SANOFI-AVENTIS U.S. LLC
$52
Exeltis, USA Inc.
$51
FIDIA PHARMA USA INC.
$51
Ferring Pharmaceuticals Inc.
$50
Mylan Institutional Inc.
$48
Antares Pharma, Inc.
$46
Kyowa Kirin, Inc.
$41
Kiniksa Pharmaceuticals, Ltd.
$39
Boston Scientific Corporation
$38
Kiniksa Pharmaceuticals International, plc
$38
Ironwood Pharmaceuticals, Inc
$38
Fresenius Kabi USA, LLC
$34
Pacira Pharmaceuticals Incorporated
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Alvogen Inc
$21
Pernix Therapeutics Holdings, Inc.
$20
Avanos Medical
$19
West-Ward Pharmaceuticals
$17
Bioventus LLC
$17
Daiichi Sankyo Inc.
$15
Avion Pharmaceuticals
$15
Kowa Pharmaceuticals America, Inc.
$13
Merck Sharp & Dohme Corporation
$13
Top 3 companies account for 59.3% of total payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · Arcalyst · BENLYSTA · Balcoltra · Bimzelx · COOLIEF COOLED RADIOFREQUENCY · COSENTYX · Cimzia · Crysvita · DUEXIS · DUZALLO · Durolane · EUFLEXXA · EVENITY · Enbrel · FORTEO · HUMIRA · HYALGAN · Hulio · Humira · Hymovis · ILARIS · INFLECTRA · INJECTAFER · Iovera · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · NEXPLANON · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · ORTHOVISC · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · QMIIZ ODT · Qutenza · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SHINGRIX · SIMPONI · SIMPONI ARIA · SKYRIZI · SOVUNA · STELARA · STRENSIQ · Seglentis · Strensiq · TALTZ · TAVNEOS · TEPEZZA · TERIPARATIDE · TREMFYA · Tavneos · Trintellix · Truxima · Tymlos · UPTRAVI · Uloric · VIMOVO · XELJANZ · XYOSTED · ZOHYDRO ER · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (58%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $29 per 100 Medicare services performed
Looking for a rheumatology in Pembroke Pines?
Compare rheumatologys in the Pembroke Pines area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
94
Per 100K population
4.8
County median income
$74,534
Nearest hospital
MEMORIAL HOSPITAL WEST
1.8 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lam is a mixed practice specialist, with above-average Medicare volume (top 17% in FL), and high industry engagement (low-engagement, top 14%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Lam experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Lam performed 67,200 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lam receive payments from pharmaceutical companies?
Yes. Dr. Lam received a total of $38,795 from 63 companies across 1,262 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lam's costs compare to other rheumatologys in Pembroke Pines?
Dr. Lam's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →